Abstract
Picking the optimal early therapy for an individual with clinically isolated syndrome (CIS) is a major objective in slowing disease progression. However, studies designed to identify which patients are at risk for developing multiple sclerosis (MS) and worsening disability have been limited. Now, investigators have conducted a large, prospective cohort study of 1015 CIS patients presenting with optic neuritis (37% of patients), brainstem symptoms (27%), …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
